Status:
UNKNOWN
Lymphedema Treatment Registry
Lead Sponsor:
Ege University
Collaborating Sponsors:
Turkish Lymphedema Society
The Breast Health Society, Turkey
Conditions:
Breast Cancer Lymphedema
Eligibility:
FEMALE
18+ years
Brief Summary
Patients with breast cancer related lymphedema (clinical stage 0-2) will include in this study. Patients will take their demographic and clinical history and will evaluate with measurements of extremi...
Detailed Description
Patients with breast cancer related lymphedema (clinical stage 0-2) will include in this study. Patients will take their demographic and clinical history and will evaluate with measurements of extremi...
Eligibility Criteria
Inclusion
- Breast cancer
- Lymphedema more than 6 months
- Lymphedema stage 0-2
- Completed treatment (CT-RT)
Exclusion
- Stage 3 lymphedema
- Cardiovasculary disease
- Hepatic disease
- Kidney disease
- Cerebrovascular event
- Metastasis
- Gastritis
- Infection
- Smoking
- Active cancer
- Bleeding history
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04272372
Start Date
October 1 2023
End Date
December 1 2025
Last Update
September 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.